Dr. Obrocea is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
28903 Avenue Paine
Valencia, CA 91355Phone+1 661-775-5365Fax+1 661-775-2080
Education & Training
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1996 - 1999
- Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 1993 - 1996
- University of OttawaMS, Biochemistry, 1990 - 1992
- Carol Davila University of Medicine and PharmacyClass of 1985
Certifications & Licensure
- CA State Medical License 2009 - 2025
- MD State Medical License 2005 - 2025
- NH State Medical License 1997 - 2025
Clinical Trials
- Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) Start of enrollment: 2005 Jan 01
- A Study of Volociximab in Metastatic Melanoma Start of enrollment: 2006 Dec 01
- A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer Start of enrollment: 2005 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 50 citationsIntra–Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical TrialAntoni Ribas, Jeffrey S. Weber, Bartosz Chmielowski, Begonya Comin-Anduix, David S.K. Lu
Clinical Cancer Research. 2011-05-01 - 1 citationsCancer vaccines at an inflexion point: what next?Adrian Bot, Mihail Obrocea, Francesco M. Marincola
Journal of Translational Medicine. 2011-09-09 - 58 citationsA Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid TumorsJeffrey S. Weber, Nicholas J. Vogelzang, Marc S. Ernstoff, Oscar B. Goodman, Lee D. Cranmer
Journal of Immunotherapy. 2011-09-01
Authored Content
- Cancer Vaccines From Research To Clinical PracticeJune 2011
- Cancer Vaccines Challenges and Opportunities in TranslationMarch 2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: